Sentry LLC’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Sentry LLC’s Portfolio LABU Stock Details LABU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-976	Closed	-$95.8K	–	125
2023 Q1	$95.8K	Buy	+976	New	+$132K	0.02%	114

Other funds holding LABU

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

IMC Chicago Chicago, Illinois $278B AUM 44.93% 1-Year Est. Return

Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return

Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Gainplan Bloomfield Hills, Michigan $254M AUM 25.62% 1-Year Est. Return

Sentry LLC's LABU Position: Q2 2023 in Review

Sentry LLC sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q2 2023, closing a stake of 976 shares — an estimated $95.8K sold.

Sentry LLC first reported a position in LABU in Q1 2023 and held it in 1 quarter. The position peaked at $95.8K in Q1 2023. 51 funds tracked by Wall St. Rank hold LABU as of Q2 2023.

Sentry LLC reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q2 2023 after selling out during the quarter.
Sentry LLC sold 976 Direxion Daily S&P Biotech Bull 3X ETF shares in Q2 2023, an estimated $95.8K.
Sentry LLC first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q1 2023 and held it in 1 quarter.
Sentry LLC's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $95.8K in Q1 2023.
51 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q2 2023.

Based on Sentry LLC's 13F filing for Q2 2023, filed 7 Mar 2024.